ClinVar Miner

Submissions for variant NM_170707.4(LMNA):c.476del (p.Glu159fs)

dbSNP: rs876657650
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000223332 SCV000271239 likely pathogenic Primary dilated cardiomyopathy 2015-05-14 criteria provided, single submitter clinical testing The p.Glu159fs variant in LMNA has not been previously reported in individuals w ith cardiomyopathy or in large population studies. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 159 and leads to a premature termination codon 18 amino acids downstrea m. This alteration is then predicted to lead to a truncated or absent protein. H eterozygous loss of LMNA function is an established disease mechanism in individ uals with DCM +/- conduction system defects. In summary, although additional stu dies are required to fully establish its clinical significance, the p.Glu159fs v ariant is likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.